Wuxi AppTec 603259.SSBehind new drug research worldwide
10.42 % of fund
Chinese company that researches, tests and makes drugs under contract for drug and biotech companies worldwide
First Plus China Equity Quantamental Alpha Fund
Shows where this fund stands in its group. Not investment advice · Data as of 4 Nov 2026
FP QUANT-I buys Chinese shares directly, with some held through ETFs or other funds
Wuxi AppTec 603259.SS10.42%
CMOC8.61%Wuxi AppTec 603259.SSChinese company that researches, tests and makes drugs under contract for drug and biotech companies worldwide
Based on the fund's weights · top 5 stocks as of 30 Sep 2026 · AMC fact sheet · Illustrations are for explanation only, not individual stock recommendations
Launched less than a year ago, so no 1-year rank yet
Each bar is one fund in the AIMC China Equity - A Shares group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 4 Nov 2026
Past performance is not a guarantee of future results
| 1W | 2W | 1M | 3M | MAX |
|---|---|---|---|---|
| +0.74% | −0.76% | −7.87% | −10.25% | −2.68% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | · | · | · | · | −0.1 | +0.9 | +6.8 | +4.1 | −5.6 | −10.1 | +2.5 | · | −2.7* |
Not enough history yet
Largest drawdown in the selected period −17.19% Previous peak 7 Aug 2026 (NAV 11.3143) → Trough 3 Nov 2026 (NAV 9.3697) · Not back to the previous peak as of 4 Nov 2026
Currently −13.98% from the peak NAV of 11.3143 (7 Aug 2026)
Over 1 year, 25 funds have data · FP QUANT-I has no data for this period yet
(1) กองทุนมีนโยบายลงทุนในตราสารทุนโดยจะเน้นลงทุนในตลาดหุ้นของบริษัทที่จดทะเบียนในตลาดหลักทรัพย์เซี่ยงไฮ้ (SSE) และตลาดหลักทรัพย์เซินเจิ้น (SZSE) ของจีนแผ่นดินใหญ่ (A-Shares) โดยมี net exposure ในตราสารดังกล่าวโดยเฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิของกองทุนรวม… Its largest holdings are WuXi AppTec Co Ltd 10.42% · CMOC Group Ltd 8.61% · China Universal CSI 800 ETF 6.70% (fact sheet 30 Sep 2026)
Risk level 6 of 8 (High risk). Since 22 May 2026, its NAV has fallen as much as −17.19% from its peak.
Actual total expense ratio (TER) 1.52% a year, against a ceiling of 4.23%. Management fee 1.00%. Front-end fee 0.00%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 10,000,000 THB, subsequent purchases not set. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+5
Hedged at the manager's discretion
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · FP QUANT-I: no dividends, TER 1.52% · FP QUANT-A: no dividends, TER 2.14%
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
CMOC CMOCChinese company mining copper and cobalt in Congo, key raw materials for EV batteries
Fund that trades on the stock exchange like a share, with its own fees
Oil, gas, power plants and tap water
Chinese state company that is one of the world's largest aluminium and alumina makers, used in cans, cars and buildings